compound introduction
(Rac)-Sograzepide is an antagonist of cholecystokinin B (CCK-B) receptor , and has the potential of reducing the secretion of gastric acid. In Vitro (Rac)-Sograzepide is an antagonist of CCK-B receptor, and has the potential of reducing the secretion of gastric acid. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:CCK-B receptor
